Leflunomide Tablet shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting 2026-06-08 · last update 2026-06-08
Manufacturers: Sanofi-Aventis U.S. LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Arava, Tablet, 10 mg (NDC 0088-2160-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 06/08/2026 Updated 06/08/2026 Discontinued 06/08/2026 |
| Arava, Tablet, 20 mg (NDC 0088-2161-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 06/08/2026 Updated 06/08/2026 Discontinued 06/08/2026 |
| Arava, Tablet, 100 mg (NDC 0088-2162-33) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 06/08/2026 Updated 06/08/2026 Discontinued 06/08/2026 |
| Leflunomide, Tablet, 10 mg (NDC 0955-1735-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 06/08/2026 Updated 06/08/2026 Discontinued 06/08/2026 |
| Leflunomide, Tablet, 20 mg (NDC 0955-1737-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 06/08/2026 Updated 06/08/2026 Discontinued 06/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)